New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

Multiple myeloma (MM) is a malignancy of clonal plasma cells accounting for approximately 10% of haematological malignancies. MM mainly affects older patients, more often males and is more frequently seen in African Americans. The most frequent manifestations of MM are anaemia, osteolytic bone lesio...

Full description

Bibliographic Details
Main Authors: Małgorzata Banaszkiewicz, Jolanta Małyszko, David H. Vesole, Karolina Woziwodzka, Artur Jurczyszyn, Marcin Żórawski, Marcin Krzanowski, Jacek Małyszko, Krzysztof Batko, Marek Kuźniewski, Katarzyna Krzanowska
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Journal of Clinical Medicine
Subjects:
anaemia
growth differentiation factor 15
hepcidin
kidney disease
mieloma multiple
soluble transferrin receptor
zonulin
Online Access:https://www.mdpi.com/2077-0383/8/11/1828

Internet

https://www.mdpi.com/2077-0383/8/11/1828

Similar Items